This site does not support your browser.

We recommend you to upgrade to the latest version:

Resume browsing

Investors Dashboard
Contact
YouTubeLinkedinInstagramFacebookTwitter
  • English
  • Spanish
PharmaMar
PharmaMar
S.A.
  • About PharmaMar
    • About PharmaMar
    • Senior Management
    • Management Team – Oncology Unit
    • Board of Directors
    • Other Businesses
    • PharmaMar in the World
    • Awards & Recognition
    • Corporate Responsibility
    • Our History
    • Presentations
  • Patients
    • Therapeutic Indications
    • Collaboration with Patient Associations
    • Clinical trial
  • YONDELIS®
  • Science & Innovation
    • R&D and Innovation
    • Oncology pipeline
    • Cofinanced projects
    • Collaboration with Scientific Associations
    • Publications
    • Mechanisms of Action
    • Medical meeting presentations
  • Shareholders and Investors
    • Financial Information
      • Annual Reports
      • Quarterly Reports
      • Financial Statements (Zeltia)
      • Average Period of Payment to Suppliers
    • Official Notices to the CNMV
      • PharmaMar
      • Zeltia
    • Share Information
      • Share Performance
      • Shares outstanding
      • Dividends
      • Significant Shareholding & Company Owned-Stock
      • Analysts
    • Debt obligations
    • Presentations
    • General Shareholders Meetings
    • Corporate Governance
      • Corporate Bylaws
      • General Shareholders’ Meeting Regulations
      • Shareholder Agreements
      • Board of Directors
      • Board of Directors Regulation
      • Annual Report on Corporate Governance
      • Annual Director Remuneration Report
      • Board Committees
      • Internal Regulation Governing Conduct
    • Contact
    • Merger PharmaMar-Zeltia
    • Política de comunicación con accionistas
  • Newsroom
    • Press Releases
    • Events Calendar
    • Multimedia
      • Videos
      • Infographics
    • Corporate Brochure
  • Careers
MENU CLOSE back  

Category Archives: CNMVEN

You are here:
  1. Home
  2. Category "CNMVEN"

Announcements of public presentations and meetings

Planes estratégicos, previsiones y presentaciones. – Convocatorias y acuerdos de Juntas y Asambleas generales

R&D: new licenses, patents and registered trademarks

R&D: new licenses, patents and registered trademarks

Announcements and agreements of shareholders general meetings. Employees share and stock ownership schemes

Strategic plans, profit forecasts and presentations

You can also read about
  • (2)Blog
  • (1)Corporate
  • (1)Employment
  • (1)Enviroment

PHARMA MAR, S.A.
VAT: ESA-78267176

Avda. De los Reyes, 1
Pol. Ind. La Mina
28770 - Colmenar Viejo
Madrid, Spain
How to get

34 91 846 6000
34 91 846 6001
pharmamar@pharmamar.com

Legal Notice
Privacy Policy
Cookies Policy

Copyright © 2019 PharmaMar - All Rights Reserved